Lonafarnib is indicated for use to lower the potential risk of Loss of life because of Hutchinson-Gilford progeria syndrome and for the treatment of sure other processing-deficient progeroid laminopathies in folks 1 calendar year of age and more mature.[three][4]The approval was granted based on clinical evidence demonstrating its efficacy and safe… Read More